drugset / Trial / NCT02014740

Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes

NCT02014740

Phase 4 Completed 100 enrolled University of Miami
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this research study is to learn about the effect of Liraglutide, (Victoza®), on the fat surrounding the heart.Excessive amount of the fat around the heart is common in people with type 2 diabetes and can be associated with poor sugar control. Liraglutide is an injectable prescription medicine that can improve blood sugar control in adults with type 2 diabetes.

Timeline

Start
2014-03
Primary completion
2017-03
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Liraglutide Peptide 1.8 mg Subcutaneous
Background Metformin Small molecule 1000 mg